163 related articles for article (PubMed ID: 8431887)
21. Oral contraceptives as related to cancer and benign lesions of the breast.
Fasal E; Paffenbarger RS
J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
[TBL] [Abstract][Full Text] [Related]
22. Risks of oral contraceptive use in women over 35.
Stenchever MA
J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
[TBL] [Abstract][Full Text] [Related]
23. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
24. Oral contraceptives and breast cancer: a French case-control study.
Clavel F; Andrieu N; Gairard B; Brémond A; Piana L; Lansac J; Bréart G; Rumeau-Rouquette C; Flamant R; Renaud R
Int J Epidemiol; 1991 Mar; 20(1):32-8. PubMed ID: 2066241
[TBL] [Abstract][Full Text] [Related]
25. Case-control study of oral contraceptive use and risk of breast cancer.
Rosenberg L; Palmer JR; Rao RS; Zauber AG; Strom BL; Warshauer ME; Harlap S; Shapiro S
Am J Epidemiol; 1996 Jan; 143(1):25-37. PubMed ID: 8533744
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer risk and oral contraceptive use: results from a large case-control study.
Weinstein AL; Mahoney MC; Nasca PC; Leske MC; Varma AO
Epidemiology; 1991 Sep; 2(5):353-8. PubMed ID: 1742384
[TBL] [Abstract][Full Text] [Related]
27. Oral contraceptives and breast cancer in northern Italy. Final report from a case-control study.
Tavani A; Negri E; Franceschi S; Parazzini F; La Vecchia C
Br J Cancer; 1993 Sep; 68(3):568-71. PubMed ID: 8353047
[TBL] [Abstract][Full Text] [Related]
28. The evaluation of the data collection process for a multicenter, population-based, case-control design.
Wingo PA; Ory HW; Layde PM; Lee NC
Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
[TBL] [Abstract][Full Text] [Related]
29. Oral contraceptives and prognosis in breast cancer: effects of duration, latency, recency, age at first use and relation to parity and body mass index in young women with breast cancer.
Holmberg L; Lund E; Bergström R; Adami HO; Meirik O
Eur J Cancer; 1994; 30A(3):351-4. PubMed ID: 8204358
[TBL] [Abstract][Full Text] [Related]
30. Oral contraceptives and breast cancer risk among younger women.
Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
Pike MC; Henderson BE; Krailo MD; Duke A; Roy S
Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of oral contraceptives and the risk of breast cancer.
Webster L
J Reprod Med; 1986 Jun; 31(6 Suppl):540-5. PubMed ID: 3723486
[TBL] [Abstract][Full Text] [Related]
33. Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.
Beaber EF; Malone KE; Tang MT; Barlow WE; Porter PL; Daling JR; Li CI
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):755-64. PubMed ID: 24633144
[TBL] [Abstract][Full Text] [Related]
34. Oral contraceptive use and breast cancer risk: a meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use.
Rushton L; Jones DR
Br J Obstet Gynaecol; 1992 Mar; 99(3):239-46. PubMed ID: 1534994
[TBL] [Abstract][Full Text] [Related]
35. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study.
Vessey M; Yeates D
Contraception; 2013 Dec; 88(6):678-83. PubMed ID: 24090961
[TBL] [Abstract][Full Text] [Related]
36. Oral contraceptives and breast cancer.
Gay JW; Cardwell MS
Mo Med; 1990 Oct; 87(10):763-7. PubMed ID: 2259330
[TBL] [Abstract][Full Text] [Related]
37. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
38. Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group.
Figueiredo JC; Bernstein L; Capanu M; Malone KE; Lynch CF; Anton-Culver H; Stovall M; Bertelsen L; Haile RW; Bernstein JL;
J Clin Oncol; 2008 Mar; 26(9):1411-8. PubMed ID: 18250348
[TBL] [Abstract][Full Text] [Related]
39. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
40. A case-control study of oral contraceptive use and breast cancer.
Hennekens CH; Speizer FE; Lipnick RJ; Rosner B; Bain C; Belanger C; Stampfer MJ; Willett W; Peto R
J Natl Cancer Inst; 1984 Jan; 72(1):39-42. PubMed ID: 6363789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
